Mylan Pantoprazolo gastro-resistant tablets

Pantoprazolo Mylan is a generic pharmaceutical product used to treat gastric acid-related conditions. The brand Mylan, which was originally an American company founded in West Virginia in 1961, underwent a significant transformation in late 2020.

Mylan merged with Pfizer's Upjohn division to form a new global healthcare entity named Viatris. Consequently, while the medication retains the 'Mylan' branding in many markets (like Italy, as shown in the image), the ultimate owner is Viatris Inc. Manufacturing for such generic medications typically occurs across a global network of specialized facilities in Europe, India, and North America to ensure supply chain stability and compliance with local health regulations.